Partner Headlines - ILMN

  1. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD
  2. IBD 50 Names Hold Gains, But Actionable Charts Scarce

    IBD
  3. Does Illumina's Latest Base Have The Profit Gene?

    IBD
  4. Quiet Stocks Are Typical In Market Right Now

    IBD
  5. IBD 50 Showing Little Distress, But Few Big Winners

    IBD
  6. Salix, Gilead Among 5 Top Medical Leaders To Watch

    IBD
  7. Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead

    IBD
  8. Gilead, Jazz Among 4 Top Big Cap Medicals To Watch

    IBD
  9. The 4 Companies Teaming Up For A New Tool To Fight Cancer

    Benzinga
  10. Illumina Joins Drugmakers To Make Cancer Test System

    IBD
  11. Illumina: Making Markets By Unlocking The Genome

    IBD
  12. Illumina lines up key partners

    IBD
  13. Illumina Forms Partnerships With Big Pharma Firms

    IBD
  14. Stocks Open Higher, Turn Mixed; Illumina Rises, Autohome Slips

    IBD
  15. US Stock Futures Surge Ahead Of Economic Data

    Benzinga
  16. Markets Mostly Higher Despite Initial Negative Reaction From ...

    Benzinga
  17. Wedbush Upgrades Illumina To Outperform, Shares Rise

    Benzinga
  18. Stocks Shave Down Early Losses; Spirit Airlines, Illumina Climb

    IBD
  19. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  20. UPDATE: Stifel Nicolaus Initiates Coverage on Illumina, Inc. ...

    Benzinga
  21. Benzinga's Top Initiations

    Benzinga
  22. Stifel Nicolaus Initiates Illumina At Buy

    Benzinga
  23. Stocks Hold Gains Midday; Walgreen Recoups Losses

    IBD
  24. UPDATE: Tigress Initiates Coverage On Illumina

    Benzinga
  25. Top Insider Sells Highlight: Illumina Inc.

    GuruFocus
  26. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  27. Stock Indexes Nearly Flat, But Apparel, Paper, Internet Shine

    IBD
  28. Under Armour, Facebook Soar As Nasdaq Turns Positive

    IBD
  29. Illumina reports robust Q2

    IBD
  30. Stocks Open Low And Soft; Baidu, Kandi, Diamonback Rise

    IBD
  31. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  32. Illumina Names Tina S. Nova As Senior Vice Pres And General Manager ...

    Benzinga
  33. Some Stock Leaders Stay Firm Amid Pullback

    IBD
  34. Several Big Cap 20 Names Near Buy Points

    IBD
  35. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD
  36. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  37. Stocks Mixed In Late Trade, But Growth Stocks Outperform

    IBD
  38. Nasdaq Showing Outperformance; GoPro Extends Gains

    IBD
  39. Novo, Other Medicals Display Healthy Action

    IBD
  40. 3 Hot Biotech Stocks Hitting Highs

    Benzinga
  41. Facebook Pops, But Key Indexes End Flat In Quiet Session

    IBD
  42. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  43. Stocks Hold Near Highs; Illumina Breakout Gains Traction

    IBD
  44. Stocks Build On Gains Backed By Strong Volume

    IBD
  45. Stocks Show Solid Gains At Midday

    IBD
  46. Stocks Reverse Into Thin Losses; Joy Global, Illumina Rocket

    IBD
  47. Five Star Biotech Stock Watch: Illumina

    Benzinga
  48. Baron Funds Comments on Illumina Inc.

    GuruFocus
  49. Baron Funds Comments on Illumina Inc.

    GuruFocus
  50. Valeant, Tesla Working On Bases As Energy Dominates

    IBD
  51. Baron Funds Comments on Illumina Inc.

    GuruFocus
  52. Nasdaq Recovers After Early Weakness; Apple Rallies Again

    IBD
  53. Illumina Reports Filing of New Patent Infringement Case Against ...

    Benzinga
  54. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  55. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  56. Gilead, Illumina Crush Views

    IBD
  57. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  58. Stocks Rise; Valeant, Netflix Soar After Hours

    IBD
  59. Analyst Bullish On Medical Research, Equipment Stocks

    IBD
  60. How To Tweak Your Retirement Portfolio For 2014 Market

    IBD
  61. Medical Research Providers Ride Higher With Biotechs

    IBD
  62. Illumina, Alexion Lead 4 Big Caps Drawing Big Buyers

    IBD
  63. Gap-Ups Point To Strength Among Select Big Caps

    IBD
  64. Illumina Inc: How Long Can a Miracle Go On?

    GuruFocus
  65. LinkedIn, TripAdvisor, Google: Top Manager's Ideas

    IBD
  66. Facebook, Biogen, Sands Among Top Big Caps Reporting

    IBD
  67. ILLUMINA

    IBD
  68. Illumina, Jazz Among 5 Young Guns Hitting New Highs

    IBD
  69. Illumina Details Its Strategy; Stock Jumps Again

    IBD
  70. US Stock Futures Surge Ahead Of Morgan Stanley Earnings

    Benzinga
  71. Illumina Announces New Organizational Alignment -8K

    Benzinga
  72. Market Wrap For January 16: Markets End Two Day Winning Streak

    Benzinga
  73. ILLUMINA

    IBD
  74. Illumina Upbeat On Q4, 2014

    IBD
  75. Illumina, Regeneron, Intuitive Q4 Results Impress

    IBD
  76. Year in Review: 2013 Innovations

    FoxBusiness
  77. Year in Review: 2013 Innovations

    FoxBusiness
  78. Benzinga's Top Initiations

    Benzinga
  79. Illumina Receives FDA Premarket Clearance for MiSeqDx System

    Benzinga
  80. Gilead Sciences Leads In Rising Short Interest Among Biotechs ...

    Benzinga
  81. Illumina Appoints Francis deSouza as President

    Benzinga
  82. Syntrix Biosystems Announces Court Upholds $115M Patent Infringement ...

    Benzinga
  83. Vipshop, 3D Systems Lead Top 5 Outperforming Stocks

    IBD
  84. Illumina Signs Agreement to Acquire NextBio, Leader in Analyzing ...

    Benzinga
  85. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics ...

    Benzinga
  86. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  87. Illumina Announces TruGenome Undiagnosed Disease Test

    Benzinga
  88. Illumina Tops Q3 Profit, Sales

    IBD
  89. Illumina Earnings, Guidance Beat Estimates Yet Again

    IBD
  90. Earnings Scheduled For October 21, 2013

    Benzinga
  91. Illumina Collaborates with University of Cambridge, Genomics ...

    Benzinga
  92. Illumina's Verinata Health Reports Expanded Test of Verifi for ...

    Benzinga
  93. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  94. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, ...

    Benzinga
  95. Illumina Applies CE Mark to Expanded MiSeqDx™ System

    Benzinga
  96. Illumina's Verinata Reports Non-invasive Verifi Prenatal Test2 ...

    Benzinga
  97. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    Benzinga
  98. UPDATE: Wells Fargo Initiates Coverage on Illumina on Prime Market ...

    Benzinga
  99. Sony and Illumina Set to Change the Way Doctors Identify and ...

    Benzinga
  100. Illumina to Supply Natera with Sequencing Instruments, Consumables ...

    Benzinga
Trading Center